36
views
0
recommends
+1 Recommend
0 collections
    2
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Noroviruses are major pathogens associated with acute gastroenteritis worldwide. Their RNA genomes are diverse, with two major genogroups (GI and GII) comprised of at least 28 genotypes associated with human disease. To elucidate mechanisms underlying norovirus diversity and evolution, we used a large-scale genomics approach to analyze human norovirus sequences. Comparison of over 2000 nearly full-length ORF2 sequences representing most of the known GI and GII genotypes infecting humans showed a limited number (≤5) of distinct intra-genotypic variants within each genotype, with the exception of GII.4. The non-GII.4 genotypes were comprised of one or more intra-genotypic variants, with each variant containing strains that differed by only a few residues over several decades (remaining “static”) and that have co-circulated with no clear epidemiologic pattern. In contrast, the GII.4 genotype presented the largest number of variants (>10) that have evolved over time with a clear pattern of periodic variant replacement. To expand our understanding of these two patterns of diversification (“static” versus “evolving”), we analyzed using NGS the nearly full-length norovirus genome in healthy individuals infected with GII.4, GII.6 or GII.17 viruses in different outbreak settings. The GII.4 viruses accumulated mutations rapidly within and between hosts, while the GII.6 and GII.17 viruses remained relatively stable, consistent with their diversification patterns. Further analysis of genetic relationships and natural history patterns identified groupings of certain genotypes into larger related clusters designated here as “immunotypes”. We propose that “immunotypes” and their evolutionary patterns influence the prevalence of a particular norovirus genotype in the human population.

          Author Summary

          Efforts are underway to develop vaccines against norovirus, a leading cause of acute gastroenteritis. The purpose of our study was to understand how norovirus strains within different genotypes evolve and adapt as they are transmitted in the human population. Using large-scale genomics and computational tools developed in our laboratory, we identified two strikingly different evolutionary patterns among norovirus genotypes: “static” and “evolving.” We mined large datasets from infection and outbreak studies in context of these evolutionary patterns and propose a new model for antigenic clustering of norovirus genotypes that could simplify vaccine design.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: not found
          • Article: not found

          Norovirus gastroenteritis.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global Causes of Diarrheal Disease Mortality in Children <5 Years of Age: A Systematic Review

            Estimation of pathogen-specific causes of child diarrhea deaths is needed to guide vaccine development and other prevention strategies. We did a systematic review of articles published between 1990 and 2011 reporting at least one of 13 pathogens in children <5 years of age hospitalized with diarrhea. We included 2011 rotavirus data from the Rotavirus Surveillance Network coordinated by WHO. We excluded studies conducted during diarrhea outbreaks that did not discriminate between inpatient and outpatient cases, reporting nosocomial infections, those conducted in special populations, not done with adequate methods, and rotavirus studies in countries where the rotavirus vaccine was used. Age-adjusted median proportions for each pathogen were calculated and applied to 712 000 deaths due to diarrhea in children under 5 years for 2011, assuming that those observed among children hospitalized for diarrhea represent those causing child diarrhea deaths. 163 articles and WHO studies done in 31 countries were selected representing 286 inpatient studies. Studies seeking only one pathogen found higher proportions for some pathogens than studies seeking multiple pathogens (e.g. 39% rotavirus in 180 single-pathogen studies vs. 20% in 24 studies with 5–13 pathogens, p<0·0001). The percentage of episodes for which no pathogen could be identified was estimated to be 34%; the total of all age-adjusted percentages for pathogens and no-pathogen cases was 138%. Adjusting all proportions, including unknowns, to add to 100%, we estimated that rotavirus caused 197 000 [Uncertainty range (UR) 110 000–295 000], enteropathogenic E. coli 79 000 (UR 31 000–146 000), calicivirus 71 000 (UR 39 000–113 000), and enterotoxigenic E. coli 42 000 (UR 20 000–76 000) deaths. Rotavirus, calicivirus, enteropathogenic and enterotoxigenic E. coli cause more than half of all diarrheal deaths in children <5 years in the world.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007.

              Noroviruses (NoVs) are the most common cause of viral gastroenteritis. Their high incidence and importance in health care facilities result in a great impact on public health. Studies from around the world describing increasing prevalence have been difficult to compare because of differing nomenclatures for variants of the dominant genotype, GII.4. We studied the global patterns of GII.4 epidemiology in relation to its genetic diversity. Data from NoV outbreaks with dates of onset from January 2001 through March 2007 were collected from 15 institutions on 5 continents. Partial genome sequences (n=775) were collected, allowing phylogenetic comparison of data from different countries. The 15 institutions reported 3098 GII.4 outbreaks, 62% of all reported NoV outbreaks. Eight GII.4 variants were identified. Four had a global distribution--the 1996, 2002, 2004, and 2006b variants. The 2003Asia and 2006a variants caused epidemics, but they were geographically limited. Finally, the 2001 Japan and 2001 Henry variants were found across the world but at low frequencies. NoV epidemics resulted from the global spread of GII.4 strains that evolved under the influence of population immunity. Lineages show notable (and currently unexplained) differences in geographic prevalence. Establishing a global NoV network by which data on strains with the potential to cause pandemics can be rapidly exchanged may lead to improved prevention and intervention strategies.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Pathog
                PLoS Pathog
                plos
                plospath
                PLoS Pathogens
                Public Library of Science (San Francisco, CA USA )
                1553-7366
                1553-7374
                19 January 2017
                January 2017
                : 13
                : 1
                : e1006136
                Affiliations
                [1 ]Caliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America
                [2 ]Bioinformatics and Computational Biosciences Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America
                [3 ]Division of Viral Products, Food and Drug Administration, Silver Spring, MD, United States of America
                Tulane University, UNITED STATES
                Author notes

                The authors have declared that no competing interests exist.

                • Conceptualization: GIP KYG.

                • Data curation: GIP JAJ CKK SVS CJL.

                • Formal analysis: GIP RBS SVS.

                • Funding acquisition: KYG.

                • Investigation: GIP JAJ CKK CJL SVS.

                • Methodology: GIP RBS.

                • Project administration: GIP KYG.

                • Resources: GIP SVS KYG.

                • Software: GIP RBS.

                • Supervision: GIP KYG.

                • Validation: GIP SVS.

                • Visualization: GIP.

                • Writing – original draft: GIP KYG.

                • Writing – review & editing: GIP RBS CKK JAJ CJL SVS KYG.

                [¤]

                Current address: Division of Viral Products, Food and Drug Administration, Silver Spring, MD, United States of America

                Author information
                http://orcid.org/0000-0002-1102-4740
                http://orcid.org/0000-0001-9666-6285
                http://orcid.org/0000-0003-2172-1387
                http://orcid.org/0000-0001-9349-3155
                http://orcid.org/0000-0002-8189-7352
                Article
                PPATHOGENS-D-16-02171
                10.1371/journal.ppat.1006136
                5283768
                28103318
                41db3268-a2b3-4a53-9862-b6311264456d

                This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

                History
                : 23 September 2016
                : 17 December 2016
                Page count
                Figures: 6, Tables: 1, Pages: 22
                Funding
                Funded by: funder-id http://dx.doi.org/10.13039/100006492, Division of Intramural Research, National Institute of Allergy and Infectious Diseases;
                Award ID: A1000897-12
                Award Recipient :
                This work was funded by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology and life sciences
                Organisms
                Viruses
                RNA viruses
                Caliciviruses
                Norovirus
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Viral Pathogens
                Caliciviruses
                Norovirus
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Viral Pathogens
                Caliciviruses
                Norovirus
                Biology and Life Sciences
                Organisms
                Viruses
                Viral Pathogens
                Caliciviruses
                Norovirus
                Biology and Life Sciences
                Genetics
                Heredity
                Genetic Mapping
                Variant Genotypes
                Biology and Life Sciences
                Molecular Biology
                Molecular Biology Techniques
                Molecular Biology Assays and Analysis Techniques
                Phylogenetic Analysis
                Research and Analysis Methods
                Molecular Biology Techniques
                Molecular Biology Assays and Analysis Techniques
                Phylogenetic Analysis
                Biology and Life Sciences
                Evolutionary Biology
                Evolutionary Immunology
                Biology and Life Sciences
                Microbiology
                Microbial Evolution
                Viral Evolution
                Biology and Life Sciences
                Evolutionary Biology
                Organismal Evolution
                Microbial Evolution
                Viral Evolution
                Biology and Life Sciences
                Microbiology
                Virology
                Viral Evolution
                Biology and Life Sciences
                Computational Biology
                Genome Evolution
                Biology and Life Sciences
                Genetics
                Genomics
                Genome Evolution
                Biology and Life Sciences
                Evolutionary Biology
                Molecular Evolution
                Genome Evolution
                Biology and Life Sciences
                Microbiology
                Microbial Mutation
                Medicine and Health Sciences
                Infectious Diseases
                Viral Diseases
                Calicivirus Infection
                Custom metadata
                vor-update-to-uncorrected-proof
                2017-01-31
                Genomic sequences determined in this study were deposited into GenBank under Accession numbers KY424328 through KY424350. All other relevant data are within the paper and its Supporting Information files.

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article